title: Chronic taurine supplementation ameliorates oxidative stress and Na+ K+ ATPase impairment in the retina of diabetic rats.
abstract: This study evaluates the effect of 4 months supplementation with 2% and 5% taurine (w/w) on the retina of diabetic rats. In non-diabetic rats, taurine does not modify glycemia, body weight, retinal conjugated dienes (CD), lipid hydroperoxide (LP), and Na(+)K(+)ATPase activity. In diabetic rat, at 2, 4, 8, 16 weeks following the onset of diabetes, retinal CD and LP are significantly and progressively increased, while pump activity is gradually and significantly reduced. In taurine supplemented diabetic rats, glycemia is not affected but lipid peroxidation is significantly decreased. Finally, taurine preserves ATPase activity being 5% more effective than 2% taurine. We conclude that taurine supplementation ameliorates biochemical retinal abnormalities caused by diabetes, thereby suggesting that taurine may have a role in the prevention of retinal changes in diabetes.
authors.affiliation: Department of Emergency Medicine, Catholic University, Rome, Italy.
authors.forename: M A S
authors.initials: MA
authors.lastname: Di Leo
authors.forename: S A
authors.initials: SA
authors.lastname: Santini
authors.forename: S
authors.initials: S
authors.lastname: Cercone
authors.forename: D
authors.initials: D
authors.lastname: Lepore
authors.forename: N
authors.initials: N
authors.lastname: Gentiloni Silveri
authors.forename: S
authors.initials: S
authors.lastname: Caputo
authors.forename: A V
authors.initials: AV
authors.lastname: Greco
authors.forename: B
authors.initials: B
authors.lastname: Giardina
authors.forename: F
authors.initials: F
authors.lastname: Franconi
authors.forename: G
authors.initials: G
authors.lastname: Ghirlanda
mesh_terms: D000818:Animals; D003921:Diabetes Mellitus, Experimental / Q000188:drug therapy / Q000378:metabolism*; D003930:Diabetic Retinopathy / Q000188:drug therapy / Q000378:metabolism*; D004032:Diet; D008297:Male; D018384:Oxidative Stress / Q000187:drug effects*; D051381:Rats; D017208:Rats, Wistar; D012160:Retina / Q000187:drug effects / Q000378:metabolism* / Q000473:pathology; D000254:Sodium-Potassium-Exchanging ATPase / Q000378:metabolism*; D013654:Taurine / Q000008:administration & dosage* / Q000378:metabolism / Q000627:therapeutic use
chemical_list: D013654:Taurine; D000254:Sodium-Potassium-Exchanging ATPase